Jacques Borger

4.6k citations

62 papers · 3.6k indexed · 1 hit paper · h-index 29

Cancer Research top 0.5%
- Breast Cancer Treatment Studies 38
Radiation top 0.5%
- Advanced Radiotherapy Techniques 24
Pathology and Forensic Medicine top 1%
- Breast Lesions and Carcinomas 13
Radiology, Nuclear Medicine and Imaging top 1%
- Medical Imaging Techniques and Applications 5
Oncology top 2%
- Cancer Treatment and Pharmacology 5
Pulmonary and Respiratory Medicine
- Lung Cancer Diagnosis and Treatment 15
- Lung Cancer Treatments and Mutations 12
Surgery
- Breast Implant and Reconstruction 10

Co-authors: Harry Bartelink Johannes L. Peterse Coen Hurkmans Alain Fourquet J.J. Jager Laurence Collette H. Struikmans M. Piérart
Cited by: Cancer Research Radiation Pathology and Forensic Medicine
Journals: Radiotherapy and Oncology (21 papers)International Journal of Radiation Oncology*Biology*Physics (12 papers)European Journal of Cancer (8 papers)
Partner nations: Netherlands United States France

In The Last Decade

Jacques Borger

59 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Jacques Borger

Since Specialization

Citations

This map shows the geographic impact of Jacques Borger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Borger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Borger more than expected).

Fields of papers citing papers by Jacques Borger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Borger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Borger. The network helps show where Jacques Borger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jacques Borger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jacques Borger Line = papers co-authored together Jacques Borger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR) Radiotherapy and Oncology ·Bart Reymen,Angela van Baardwijk,Rinus Wanders,Jacques Borger,Anne‐Marie C. Dingemans,Gerben Bootsma,Cordula Pitz,Ragnar Lunde,Wiel Geraedts,Philippe Lambin,Dirk De Ruysscher	2014	19
2	Set-up verification and 2-dimensional electronic portal imaging device dosimetry during breath hold compared with free breathing in breast cancer radiation therapy Practical Radiation Oncology ·Selma F. Knijnik,Tim Lustberg,Jacques Borger,W. R. Cho,J.J. Jager,L. Murrer,Hosny Abd-El-Dayem,Yerru Bhavitha,R.R. Lee,Liesbeth Boersma	2014	17
3	A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: A step toward individualized care and shared decision making Radiotherapy and Oncology ·Cary Oberije,Georgi Nalbantov,André Dekker,Liesbeth Boersma,Jacques Borger,Bart Reymen,Angela van Baardwijk,Rinus Wanders,Dirk De Ruysscher,Ewout W. Steyerberg,Anne‐Marie C. Dingemans,Philippe Lambin	2014	75
4	Total Gross Tumor Volume Is an Independent Prognostic Factor in Patients Treated With Selective Nodal Irradiation for Stage I to III Small Cell Lung Cancer International Journal of Radiation OncologyBiologyPhysics ·Bart Reymen,Judith van Loon,Angela van Baardwijk,Rinus Wanders,Jacques Borger,Anne‐Marie C. Dingemans,Gerben Bootsma,Cordula Pitz,Ragnar Lunde,Wiel Geraedts,Philippe Lambin,Dirk De Ruysscher	2012	34
5	Also elderly patients (75 years or older) with stage III non-small cell lung cancer (nsclc) have survival gains with radical treatment: a prospective population-based study Journal of Thoracic Oncology ·Jessie Steevens,Dirk De Ruysscher,Anita A.M. Botterweck,Bart Reymen,Angela van Baardwijk,Rinus Wanders,Jacques Borger,Anne‐Marie C. Dingemans,Gerben Bootsma,Cordula Pitz,Ragnar Lunde,Wiel Geraedts,Philippe Lambin	2011	1
6	Results of a phase II trial on individualized radiation dose-escalation based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer (NSCLC) Journal of Thoracic Oncology ·Angela van Baardwijk,Bart Reymen,Rinus Wanders,Jacques Borger,Anne‐Marie C. Dingemans,Gerben Bootsma,Cordula Pitz,Ragnar Lunde,Wiel Geraedts,刘光利,Philippe Lambin,Dirk De Ruysscher	2011	0
7	Is contrast enhancement required to visualize a known breast tumor in a pre-operative CT scan? Radiotherapy and Oncology ·Liesbeth Boersma,刘九皋,C. Boetes,Jacques Borger,Piet van den Ende,信亲林,Ruud Houben,J.J. Jager,L. Murrer,S H Sastrowijoto,Angela van Baardwijk	2011	3
8	Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study Radiotherapy and Oncology ·Dirk De Ruysscher,Angela van Baardwijk,Jessie Steevens,Anita A.M. Botterweck,Geert Bosmans,Bart Reymen,Rinus Wanders,Jacques Borger,Anne‐Marie C. Dingemans,Gerben Bootsma,Cordula Pitz,Ragnar Lunde,Wiel Geraedts,M. Oellers,André Dekker,Philippe Lambin	2011	39
9	The Use of FDG-PET to Target Tumors by Radiotherapy Strahlentherapie und Onkologie ·Guido Lammering,Dirk De Ruysscher,Angela van Baardwijk,Brigitta G. Baumert,Jacques Borger,Ludy Lutgens,Piet van den Ende,Michel Öllers,Philippe Lambin	2010	42
10	Customized Computed Tomography-Based Boost Volumes in Breast-Conserving Therapy: Use of Three-Dimensional Histologic Information for Clinical Target Volume Margins International Journal of Radiation OncologyBiologyPhysics ·刘九皋,Jacques Borger,Piet van den Ende,曾昭贤,Ruud Houben,J.J. Jager,Kristien Keymeulen,L. Murrer,S H Sastrowijoto,Koen Van de Vijver,Liesbeth Boersma	2009	20
11	Evaluation of three different CT simulation and planning procedures for the preoperative irradiation of operable rectal cancer Radiotherapy and Oncology ·Jacques Borger,Jørgen van den Bogaard,Markéta Kuhnová,Anne Großkurth,L. Murrer,Ruud Houben,Guido Lammering	2008	7
12	18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: A planning study Radiotherapy and Oncology ·Judith van Loon,陆敏菊,Geert Bosmans,Rinus Wanders,André Dekker,Jacques Borger,M. Oellers,Anne‐Marie C. Dingemans,Angela van Baardwijk,Jaap Teule,Gabriël Snoep,Monique Hochstenbag,Ruud Houben,Philippe Lambin,Dirk De Ruysscher	2008	59
13	Prone breast irradiation for pendulous breasts Radiotherapy and Oncology ·Jeroen Buijsen,J.J. Jager,Alfredo Canellas Guilherme da Silva,F Tuijman,Jacques Borger,Liesbeth Boersma,L. Murrer,Philippe Lambin	2006	46
14	Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run Radiotherapy and Oncology ·Coen Hurkmans,Jacques Borger,Emiel J. Rutgers,Geertjan van Tienhoven	2003	45
15	Minder lokale recidieven van borstkanker door extra lokale bestralingsdosis na mammasparende chirurgie: 5-jaarsresultaten van een klinische trial Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·H. Bartelink,P Poortmans,Rebecca Carey Lyles,Jacques Borger,Justyna Rajchert,W.J. Hoogenraad,W. Van den Bogaert,I. Barillot,Alain Fourquet,Laurence Collette,M. Piérart,J.C. Horiot	2002	1
16	Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy Cancer ·Nina Bijker,Emiel J. Rutgers,Johannes L. Peterse,J.A. van Dongen,Manuel López‐Aliste,Jacques Borger,Bin B. R. Kroon	1999	2
17	Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy Cancer ·Nina Bijker,Emiel J. Rutgers,Johannes L. Peterse,J.A. van Dongen,Manuel López‐Aliste,Jacques Borger,Bin B. R. Kroon	1999	20
18	Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement The Lancet ·Sjoerd Rodenhuis,Dick J. Richel,Elsken van der Wall,Jan H. Schornagel,Joke W. Baars,Caro C.E. Koning,Johannes L. Peterse,Jacques Borger,Willem J. Nooijen,Roel Bakx,Otilia Dalesio,Emiel J. Rutgers	1998	182
19	Dose and volume effects on fibrosis after breast conservation therapy International Journal of Radiation OncologyBiologyPhysics ·Jacques Borger,Carame’S Beatriz,O. Yoko,Augustinus A. M. Hart,Shikang Liu,Joos V. Lebesque,Harry Bartelink	1994	125
20	The impact of surgical and pathological findings on radiotherapy of early breast cancer Radiotherapy and Oncology ·Jacques Borger	1991	17

About Jacques Borger

Jacques Borger is a scholar working on Radiation, Cancer Research and Otorhinolaryngology, having authored 62 papers that have together received 3.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (38 papers), Advanced Radiotherapy Techniques (24 papers), Lung Cancer Diagnosis and Treatment (15 papers), Breast Lesions and Carcinomas (13 papers), Lung Cancer Treatments and Mutations (12 papers), Breast Implant and Reconstruction (10 papers), Medical Imaging Techniques and Applications (5 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Cancer Research (2.2k citations), Radiation (1.1k citations) and Pathology and Forensic Medicine (1.1k citations). Jacques Borger has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Harry Bartelink, Johannes L. Peterse, Coen Hurkmans, Alain Fourquet, J.J. Jager, Laurence Collette, H. Struikmans, M. Piérart, Jean-Claude Horiot and Philip Poortmans. Their work appears in journals such as Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer, Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact